Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407)

Tomohiro Nishina, Narikazu Boku, Masahiro Gotoh, Yasuhiro Shimada, Yasuo Hamamoto, Hirofumi Yasui, Kensei Yamaguchi, Hiroki Kawai, Norisuke Nakayama, Kenji Amagai, Junki Mizusawa, Kenichi Nakamura, Kuniaki Shirao, Atsushi Ohtsu

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407)'. Together they form a unique fingerprint.

Medicine & Life Sciences